The neurobiology of Rett syndrome

Neuroscientist

Volumn 9, Issue 1, 2003, Pages 57-63

  Akbarian, Schahram ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Chromatin; Developmental disorders; DNA methylation; Epigenetics

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ASTROCYTE; BRAIN WEIGHT; CELLULAR DISTRIBUTION; CHROMATIN; CHROMOSOME STRUCTURE; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DNA METHYLATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; GLIA; HETEROCHROMATIN; MENTAL DISEASE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM; NEUROBIOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPATHY; ONSET AGE; PERICENTRIC CHROMOSOME INVERSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RETT SYNDROME; REVIEW; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

ANIMALS; BRAIN; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; GENE SILENCING; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; NEURONS; REPRESSOR PROTEINS; RETT SYNDROME; TRANSCRIPTION, GENETIC;

EID: 0037310609     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858402239591     Document Type: Review

References (55)

1. Akbarian S, Chen RZ, Gribnau J, Rasmussen TP, Fong H, Jaenisch R, and others. 2001. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 8:784-91.
2. Akhmanova A, Verkerk T, Langeveld A, Grosveld F, Galjart N. 2000. Characterisation of transcriptionally active and inactive chromatin domains in neurons. J Cell Sci 113:4463-74.
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet 23:185-8.
4. Armstrong DD. 2000. Rett syndrome neuropathology review 2000. Brain Dev 23(Suppl 1):S72-6.
5. Armstrong DD, Dunn JK, Antalffy B, Trivedi R. 1995. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropath Exp Neurol 54:195-201.
6. Armstrong DD, Dunn JK, Schultz RJ, Herbert DA, Glaze DG, Motile KJ. 1999. Organ growth in Rett syndrome, a post mortem examination analysis. Pediatr Neurol 20:125-9.
7. Balmer D, Arredondo J, Samaco RC, LaSalle JM. 2002. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110:545-52.
8. Bauman ML, Kemper TK, Arin DM. 1995. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett syndrome. Neurology 45:1581-6.
9. Berman KF, Torrey EF, Daniel DG, Weinberger DR. 1992. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 49:927-34.
10. Bird A. Guy J, Selfridge J, Barr H, Hendrich H., Kriaucionis S, and others. 2002. Functional studies of Mecp2-null mice. RSRF 3rd Ann Rett Syndrome Symposium, Baltimore, MD. p 12.
11. Bird AP, Wolffe AP. 1999. Methylation-induced repression - belts, braces, and chromatin. Cell 99:451-4.
12. Carter AR, Segal RA. 2001. Rett syndrome model suggests MECP2 gives neurons the quiet they need to think. Nat Neurosci 4:342-3.
13. Chandler SP, Guschin D, Landsberger N, Wolffe AP. 1999. The methylCpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38:7008-18.
14. Chelly J, Mandel JL. 2001. Monogenic causes of X-linked mental retardation. Nat Rev Genet 2:669-80.
15. Chen RZ, Akbarian S, Tudor M, Jaenisch R. 2001. Deficiency of methyl-CpG binding protein-2.in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-31.
16. Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, and others. 2001. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 8:947-65.
17. Coy JF, Sedlacek Z, Bachner D, Delius H, Poustka A. 1999. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet 8:1253-62.
18. Francke U. 2002. Understanding Rett Syndrome - Where are we? RSRF 3rd Ann Rett Syndrome Symposium, Baltimore, MD. p 1.
19. Franzen G, Ingvar DH. 1975. Abnormal distribution of cerebral activity in chronic schizophrenia. J Psychiatr Res 12:199-214.
20. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-6.
21. Hagberg, B. 1985. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 74:405-8.
22. Hansen JC, Georgel P, Wade H. 2002. In vitro interactions of native and mutant MeCP2 with DNA and chromatin. RSRF 3rd Ann Rett Syndrome Symposium, Baltimore, MD. p 24.
23. Henikoff S, Ahmad K, Malik HS. 2001. The centromere paradox: stable inheritance with rapidly evolving DNA. Science 293:1098-102.
24. Huppke P, Held M, Hanefeld F, Engel W, Laccone F. 2002. Influence of mutation type and location on phenotype in 123 patients with rett syndrome. Neuropediatrics 33:63-8.
25. Jaenisch R, Luikenhuis S, Tudor M, Beard C, Chang Q. 2002. Molecular analysis of Mecp2 deficiency in mice. RSRF 3rd Ann Rett Syndrome Symposium, Baltimore, MD. p 10.
26. Jellinger K, Armstrong D, Zoghbi HY, Percy AK. 1988. Neuropathology of Rett syndrome. Acta Neuropathol 76:142-58.
27. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, and others. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-91.
28. Kaludov NK, Wolffe AP. 2000. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res 28:1921-8.
29. Kaufmann WE. 2002. MeCP2 expression in human neocortex. RSRF 3rd Annual Rett Syndrome Symposium, Baltimore, MD. p 21.
30. Kerr AM, Nomura Y, Armstrong D, Anvret M, Belichenko PV, Budden S, and others. 2001. Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev 23:208-11.
31. Kudo S. 1998. Methyl-CpG-binding protein MeCP2 represses Sp1- activated transcription of the human leukosialin gene when the promoter is methylated. Mol Cell Biol 18:5492-9.
32. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, and others. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
33. Lewis JD, Meehan RR, Wenzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, and others. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:905-14.
34. Liang F, Jones EG. 1997. Differential and time-dependent changes in gene expression for type II calcium/calmodulin-dependent protein kinase, 67 kDa glutamic acid decarboxylase, and glutamate receptor subunits in tetanus toxin-induced focal epilepsy. J Neurosci 17:2168-80.
35. Marin-Padilla M. 1988. Early ontogenesis of the human cerebral cortex. In: Peters A, Jones EG, editors. Cerebral cortex, Vol. 7. New York: Plenum. p 1-30.
36. Mimics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
37. Naidu S. 1997. Rett syndrome: a disorder affecting early brain growth. Ann Neurol 42:3-10.
38. Nan X, Campoy FJ, Bird A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471-81.
39. Nan X, Meehan RR, Bird A. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21:4886-92.
40. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, and others. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-9.
41. Nielsen JB, Friberg L, Lou H, Lassen NA, Sam IL. 1990. Immature pattern of brain activity in Rett syndrome. Arch Neurol 47:982-6.
42. Partridge JF, Borgstrom B, Allshire RC. 2000. Distinct protein interaction domains and protein spreading in a complex centromere. Genes Dev 14:783-91.
43. Percy AK. 2001. Rett syndrome: clinical correlates of the newly discovered gene. Brain Dev 23(Suppl 1):S202-5.
44. Rakic P. 1974. Neurons in rhesus monkey visual cortex: systematic relationship between time of origin and eventual disposition. Science 183:425-7.
45. Rett A. 1966. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116:723-6.
46. Schanen C. 2001. Rethinking the fate of males with mutations in the gene that causes Rett syndrome. Brain Dev 23(Suppl 1):S144-6.
47. Schultz RJ, Glaze DG, Motil KJ, Armstrong DD, del Junco DJ, Hubbard CR, and others. 1993. The pattern of growth failure in Rett syndrome. Am J Dis Child 147:633-7.
48. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. 2002. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115-24.
49. Subramaniam B, Naidu S, Reiss AL. 1997. Neuroanatomy in Rett Syndrome: cerebral cortex and posterior fossa. Neurology 48:399-407.
50. Taddei A, Maison C, Roche D, Almouzni G. 2001. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol 3:114-20.
51. Tudor M, Akbarian S, Chen RZ, Jaenisch R. 2002. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in brain. Proc Natl Acad Sci USA 99:15536-41.
52. Van den Veyver IB, Zoghbi HY. 2001. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome. Brain Dev 23(Suppl 1):S147-51.
53. Watson P, Black G, Ramsden S, Barrow M, Super M, Kerr B, and others. 2001. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38:224-8.
54. Weitzel JM, Buhrmester H, Stratling WH. 1997. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol Cell Biol 17:5656-66.
55. Yu F, Zingler N, Schumann G, Stratling WH. 2001. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res 29:4493-501.